Daniel S. Hoffman

Associate
Boston Waltham | Boston
  • 1000 Winter Street
  • Suite 3700
  • Waltham, MA 02451
  • USA
Profile Experience

Daniel Hoffman is a member of the firm's Emerging Companies Practice. He represents technology and life sciences companies from startup through IPO.

Mr. Hoffman advises companies in the areas of:

  • Early-stage formation and strategy
  • Venture capital financings
  • Public offerings of securities
  • Mergers and acquisitions
  • Corporate governance issues

Mr. Hoffman’s recent representative transactions include advising:

  • ASAPP in multiple venture capital financings
  • Portal Instruments in multiple venture capital financings
  • Omio in multiple venture capital financings
  • Drizly in multiple venture capital financings
  • Rent the Runway in its Series D financing
  • OmniSci in multiple venture capital financings
  • CloudHealth in its sale to VMWare
  • The Echo Nest in its sale to Spotify
  • SpaceClaim in its sale to ANSYS
  • Amphenol in its acquisition of SSI Controls Technologies
  • LogMeIn in its acquisition of the GoTo Business of Citrix Systems
  • Veracode in its sale to CA Technologies
  • CityMaps in its sale to TripAdvisor
  • Cartera in its sale to Ebates

Mr. Hoffman has provided a wide range of general corporate advice to numerous other emerging growth companies, including:

  • Alignable
  • Dynometrics
  • EarPlay
  • Envoy Global
  • Keybase
  • Lumesis
  • Neumitra
  • Organica Water
  • Pison Technology
  • RapidDeploy
  • Raise Marketplace
  • Realtime Robotics
  • Reonomy
  • Unlearn.ai
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.